Chapter 24. Preventing Recurrence of Hepatocellular Carcinoma after Curative Resection

  1. Pierre-Alain Clavien MD, Phd, FACS, FRCS Professor Chairman and
  2. Stefan Breitenstein MD
  1. Stefan Breitenstein MD2,
  2. Dimitris Dimitroulis MD2 and
  3. Beat Müllhaupt1

Published Online: 9 DEC 2009

DOI: 10.1002/9781444317053.ch24

Malignant Liver Tumors: Current and Emerging Therapies, Third Edition

Malignant Liver Tumors: Current and Emerging Therapies, Third Edition

How to Cite

Breitenstein, S., Dimitroulis, D. and Müllhaupt, B. (2010) Preventing Recurrence of Hepatocellular Carcinoma after Curative Resection, in Malignant Liver Tumors: Current and Emerging Therapies, Third Edition (eds P.-A. Clavien and S. Breitenstein), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444317053.ch24

Editor Information

  1. Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland

Author Information

  1. 1

    Department of Gastroenterology and Hepatology, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland

  2. 2

    Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland

Publication History

  1. Published Online: 9 DEC 2009
  2. Published Print: 12 JAN 2010

ISBN Information

Print ISBN: 9781405179768

Online ISBN: 9781444317053

SEARCH

Keywords:

  • Hepatocellular carcinoma (HCC);
  • Immunotherapy with interferon (IFN);
  • randomized controlled trials (RCT);
  • Iodine-131-labelled lipiodol;
  • Retinoids;
  • Preventing Recurrence of Hepatocellular Carcinoma;
  • Virus (hepatitis C [HCV] and B [HBV] viruses)

Summary

This chapter contains sections titled:

  • Introduction

  • Interferon

  • Iodine-131-l abelled lipiodol

  • Retinoids

  • Other potential approaches for secondary prevention

  • Conclusion

  • Self-assessment questions

  • References

  • Self-assessment answers